SELLAS Life Sciences (SLS) Revenue (2012 - 2022)

SELLAS Life Sciences (SLS) has reported Revenue for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2022.

• In Q1 2022, Revenue fell 82.46% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $1.0 million (down 86.84% YoY), while the FY2022 annual figure was $1.0 million, down 86.84% from the prior year.
• Revenue retreated to $1.0 million in Q1 2022 per SLS's latest filing, from $1.9 million in the prior quarter.
• Across five years, Revenue topped out at $5.7 million in Q1 2021 and bottomed at $1.0 million in Q1 2022.
• Historically, Revenue has averaged $2.6 million across 3 years, with a median of $1.9 million in 2020.
• On a YoY basis, Revenue climbed as much as 82.46% in 2022 and fell as far as 82.46% in 2022.
• SELLAS Life Sciences' Revenue stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then slumped by 47.37% to $1.0 million in 2022.
• Business Quant data shows SLS's Revenue at $1.0 million in Q1 2022, $1.9 million in Q2 2021, and $5.7 million in Q1 2021.